Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REVB | AMGN | REGN | VRTX | BMY |
| Company | Revelation Biosciences Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9000 | 327.96 | 1,160.74 | 480.00 | 48.25 |
| High | 0.9249 | 334.45 | 1,170.58 | 486.06 | 49.15 |
| Low | 0.8600 | 327.15 | 1,150.02 | 478.75 | 48.20 |
| Last | 0.8990 | 332.45 | 1,153.35 | 485.37 | 49.13 |
| Change | -0.0110 | +2.39 | -11.11 | +6.72 | +0.89 |
| % Change | -1.21% | +0.72% | -0.95% | +1.40% | +1.84% |
| Volume | 148,700 | 1,397,000 | 353,600 | 700,800 | 9,412,899 |
| 20-Day Average Volume | 4,885,270 | 1,649,670 | 425,635 | 988,995 | 8,800,405 |
| Previous Close | 0.9100 | 330.06 | 1,164.46 | 478.65 | 48.24 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0612 | 328.09 | 1,173.76 | 480.67 | 48.98 |
| 20-Day Raw Stochastic | 3.31% | 80.73% | 40.95% | 62.39% | 58.09% |
| 20-Day Relative Strength | 41.84% | 55.48% | 53.83% | 53.77% | 56.05% |
| Weighted Alpha | -88.36 | +27.93 | +42.47 | +37.14 | -11.27 |
| Today's Opinion | 100% Sell | 88% Buy | 80% Buy | 72% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 80% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 100% Buy | 56% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.32% since 09/06/24 | +3.71% since 09/06/24 | +1.93% since 09/06/24 | +3.71% since 09/06/24 | +0.88% since 09/06/24 |
| Low | 0.8310 on 09/10/24 | 320.10 on 09/09/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 47.55 on 09/09/24 |
| High | 0.9800 on 09/12/24 | 334.45 on 09/13/24 | 1,170.58 on 09/13/24 | 486.06 on 09/13/24 | 49.31 on 09/10/24 |
| 1-Month | |||||
| %Chg | -0.11% since 08/13/24 | +2.78% since 08/13/24 | -0.43% since 08/13/24 | +3.80% since 08/13/24 | +0.14% since 08/13/24 |
| Low | 0.8100 on 08/16/24 | 319.00 on 09/06/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 46.88 on 08/22/24 |
| High | 3.5000 on 08/21/24 | 335.66 on 08/30/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | -60.22% since 06/13/24 | +11.37% since 06/13/24 | +12.35% since 06/13/24 | +1.32% since 06/13/24 | +18.44% since 06/13/24 |
| Low | 0.8100 on 08/16/24 | 295.90 on 06/14/24 | 1,011.67 on 07/03/24 | 458.04 on 08/13/24 | 39.35 on 07/05/24 |
| High | 3.8000 on 06/24/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -65.42% since 03/13/24 | +20.46% since 03/13/24 | +19.46% since 03/13/24 | +17.47% since 03/13/24 | -6.69% since 03/13/24 |
| Low | 0.8100 on 08/16/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 3.8000 on 06/24/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 54.47 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,468 | 178,337,824 | 127,083,008 | 125,251,192 | 99,591,424 |
| Shares Outstanding, K | 1,633 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -120,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -8,390,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | 0.19 | 0.61 | 0.12 | 0.40 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.54 on 08/09/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/09/24 | 10/29/24 | 11/07/24 | 11/04/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.75 | 30.31 | 0.00 | 35.21 |